CTOs on the Move

Monogram BioSciences

www.monogrambio.com

 
Monogram Biosciences, Inc. (Monogram) is a life sciences company committed to advancing personalized medicine and improving patient outcomes through the development of molecular diagnostic products that guide and target the appropriate treatments
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million
  • www.monogrambio.com
  • 345 Oyster Point Blvd
    South San Francisco, CA USA 94080
  • Phone: 650.635.1100

Executives

Name Title Contact Details

Similar Companies

Greenstone

Greenstone is a Peapack, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Reditus Laboratories

Reditus Laboratories is a full-service laboratory company. We are committed to providing our client physicians with top-tier, accurate anatomical and clinical pathology services.

Industrial Facilities Design Inc

Industrial Facilities Design Inc is a Hopkinton, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Avadel

Avadel Pharmaceuticals plc (NASDAQ: AVDL) is a specialty pharmaceutical company that seeks to develop differentiated pharmaceutical products that are safe, effective and easy to take, helping patients adhere to their prescribed medical treatment and see better results. Avadel`s current portfolio of products and product candidates focuses on the urology, central nervous system (CNS) / sleep, and hospital markets. The Company is headquartered in Dublin, Ireland with operations in St. Louis, Missouri and Lyon, France.

KCR

KCR is a clinical development solutions provider for the biotechnology, pharmaceutical, and medical device industries. We support clients with full-service clinical development capabilities across three main areas: Trial Execution, Consulting and Placement. KCR operates across four main regions: North America, Western Europe, Central Europe, and Eastern Europe, with a main operational hub located in Boston, MA. Our strategic hub locations, technical capabilities and solution offerings allow for the optimized delivery of trial execution strategies to develop life-changing therapies. KCR offers access to an estimated population of 1.1 Billion people.